1. Jalilian, A. R., Osso Jr, J., “The current status and future of theranostic Copper-64 radiopharmaceuticals”, Iranian Journal of Nuclear Medicine 2017, 25 (1), 1–10
2. https://www-nds.iaea.org/exfor/
3. A. N. Asabella, G. L. Cascini, C. Altini, D. Paparella, A. Notaristefano, G. Rubini, “The copper radioisotopes: a systematic review with special interest to 64Cu”, BioMed Research. International, 2014, 1–9
4. Bé, M.-M, Chisté, V; Dulieu, C., Mougeot, X., Chechev, V., Kuzmenko, N., Kondev, F., Luca, A., Galán, M., Nichols, A. L., Lee, K. B., Arinc, A., Pearce, A., Huang, X., Wang, B. "Cu-64" (PDF). In Bé, M.-M. Table of radionuclides (Volume 6). Sèvres: (2006) BIPM. p. 13. ISBN 978-92-822-2242-3.
5. Efficient production of high specific activity 64Cu using a biomedical cyclotron